According to The Insight Partners, Global Enteric Disease Testing Market size is expected to reach US$ 5.47 Billion by 2034 from US$ 4.00 Billion in 2025. The market is anticipated to register a CAGR of 3.54% during the forecast period 2026–2034.
The Enteric Disease Testing Market is witnessing steady expansion driven by rising awareness of gastrointestinal infections, increasing global travel, and the growing need for rapid diagnostic solutions. Enteric diseases—primarily caused by bacterial, viral, and parasitic pathogens—remain a major global health concern, prompting healthcare systems to invest in advanced diagnostic technologies for faster detection and treatment.
Get a Sample PDF – https://www.theinsightpartners.com/sample/TIPRE00004384
The growing burden of foodborne and waterborne illnesses worldwide is a major factor contributing to market growth. Increasing outbreaks of infections caused by pathogens such as Salmonella, E. coli, Shigella, and norovirus are pushing healthcare authorities to adopt efficient testing solutions. Diagnostic laboratories and hospitals are increasingly deploying molecular and rapid testing methods to reduce diagnostic turnaround time and improve patient outcomes.
Market Drivers
Rising Incidence of Foodborne and Waterborne Diseases
One of the strongest drivers of the enteric disease testing market is the increasing incidence of food and water contamination. Urbanization, climate change, and globalized food supply chains have increased the risk of pathogen transmission. Developing countries face persistent sanitation challenges, while developed economies continue to experience outbreaks linked to food imports and mass food production.
Governments and health agencies worldwide are implementing stricter food safety regulations and surveillance programs. This has significantly increased demand for diagnostic testing in both clinical and public health laboratories. Early detection of pathogens is critical for outbreak containment, which is accelerating the adoption of advanced testing technologies.
Growing Adoption of Molecular Diagnostic Technologies
Technological advancements in molecular diagnostics—especially PCR-based testing—are transforming enteric disease detection. Traditional culture-based methods, while reliable, often require several days for results. In contrast, molecular techniques offer faster, highly sensitive, and accurate detection of multiple pathogens simultaneously.
Multiplex PCR panels, next-generation sequencing (NGS), and point-of-care molecular diagnostics are gaining traction. These technologies enable clinicians to diagnose infections rapidly and prescribe targeted treatments, reducing unnecessary antibiotic use and improving patient outcomes.
The shift toward syndromic testing panels that can detect multiple gastrointestinal pathogens in a single test is a key growth catalyst. Hospitals and laboratories are increasingly investing in automated diagnostic platforms to improve efficiency and throughput.
Increasing Healthcare Expenditure and Diagnostic Infrastructure
Rising healthcare expenditure worldwide is another significant factor driving market growth. Governments and private healthcare providers are investing in modern diagnostic infrastructure to enhance disease surveillance and response capabilities. Emerging economies in Asia-Pacific, Latin America, and the Middle East are expanding their laboratory networks, which is boosting demand for enteric disease testing solutions.
In addition, public health initiatives aimed at controlling infectious diseases are encouraging routine screening and early detection programs. This is particularly important in pediatric and geriatric populations, which are more vulnerable to severe gastrointestinal infections.
Rising Awareness and Preventive Healthcare Initiatives
Public awareness campaigns about hygiene, sanitation, and food safety have increased demand for diagnostic testing. Preventive healthcare strategies emphasize early detection and treatment to minimize complications and healthcare costs. Educational campaigns by health organizations are encouraging individuals to seek timely medical care for gastrointestinal symptoms.
The growing emphasis on preventive healthcare is also encouraging routine testing in high-risk populations, including travelers, immunocompromised individuals, and healthcare workers.
Growth in Travel and Global Mobility
International travel and migration have increased the risk of cross-border transmission of enteric pathogens. Travelers often encounter unfamiliar food and water sources, increasing the likelihood of infection. As a result, travel medicine clinics and healthcare providers are increasingly recommending diagnostic testing for returning travelers presenting with gastrointestinal symptoms.
The expansion of the tourism industry and business travel is expected to continue driving demand for enteric disease testing services over the forecast period.
Increasing Antibiotic Resistance Concerns
Antimicrobial resistance (AMR) is becoming a major global health challenge. Misuse and overuse of antibiotics have led to the emergence of resistant strains of enteric pathogens. Accurate and timely diagnosis is essential to guide appropriate treatment and reduce the misuse of antibiotics.
Advanced diagnostic tests that identify specific pathogens help clinicians prescribe targeted therapies, reducing reliance on broad-spectrum antibiotics. This trend is expected to significantly boost the adoption of enteric disease testing solutions.
Expansion of Point-of-Care Testing
Point-of-care testing (POCT) is emerging as a transformative trend in the enteric disease testing market. Portable and rapid diagnostic tools enable testing in remote and resource-limited settings, reducing the need for centralized laboratories. These solutions are particularly valuable in rural areas and developing countries where access to healthcare facilities is limited.
The integration of digital health technologies and connectivity features in POCT devices is further enhancing their adoption, enabling real-time data sharing and surveillance.
Market Trends and Opportunities
The market is witnessing a shift toward automation, digital integration, and high-throughput testing platforms. Artificial intelligence and data analytics are increasingly being used to interpret diagnostic results and track disease outbreaks. Additionally, partnerships between diagnostic companies and public health organizations are strengthening disease monitoring and response capabilities.
Emerging economies present significant growth opportunities due to improving healthcare infrastructure and rising awareness of infectious diseases. Increasing investments in research and development are expected to lead to innovative testing solutions with higher accuracy and efficiency.
Key Players in the Enteric Disease Testing Market
Leading companies operating in the market include:
- Abbott Laboratories
- bioMérieux SA
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- BD (Becton, Dickinson and Company)
- Qiagen N.V.
- F. Hoffmann-La Roche Ltd.
- Hologic, Inc.
- Bio-Rad Laboratories, Inc.
- Cepheid
These companies are focusing on product innovation, strategic collaborations, and geographic expansion to strengthen their market presence.
Get Premium Research Report Market Size and Growth Report at:
https://www.theinsightpartners.com/buy/TIPRE00004384
Future Outlook
The Enteric Disease Testing Market is set for steady growth through 2034, driven by rising disease prevalence, technological advancements, and increased healthcare investments. The growing demand for rapid and accurate diagnostic solutions will continue to shape the competitive landscape, creating opportunities for innovation and expansion.
About Us
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Contact Us
Ankit Mathur | The Insight Partners
E-mail: ankit.mathur@theinsightpartners.com
Phone: +1-646-491-9876
Also Available in : Korean | German | Japanese | French | Chinese | Italian | Spanish